MEDIR FERRER Y CIA, S.A., commonly referred to as Medir Ferrer, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Spain. Established in 1985, the company has made significant strides in the development and distribution of high-quality medical products, primarily focusing on the fields of diagnostics and therapeutics. With a strong presence in both domestic and international markets, Medir Ferrer is renowned for its innovative solutions, including advanced diagnostic kits and specialised medical devices. The company’s commitment to quality and excellence has positioned it as a trusted partner in healthcare, achieving notable milestones in product development and market expansion. Medir Ferrer continues to lead the way in providing unique, reliable healthcare solutions that meet the evolving needs of the medical community.
How does MEDIR FERRER Y CIA, S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MEDIR FERRER Y CIA, S.A.'s score of 36 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MEDIR FERRER Y CIA, S.A., headquartered in Spain, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of IMCD N.V., which influences its climate commitments and emissions reporting. As a part of this corporate family, any potential emissions data or reduction targets would be inherited from IMCD N.V. at a cascade level of 2. Despite the absence of direct emissions data, it is important to note that MEDIR FERRER Y CIA, S.A. is aligned with the sustainability initiatives of its parent company. IMCD N.V. has established various climate commitments, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide their emissions reduction strategies. As of now, MEDIR FERRER Y CIA, S.A. has not set specific reduction targets or made significant public commitments towards carbon neutrality. The company’s climate strategy may evolve as it continues to align with the broader sustainability goals of IMCD N.V. and the industry at large.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MEDIR FERRER Y CIA, S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.